Published Papers & Misc - FUJII Yasuhisa

Division display  61 - 80 of about 372 ／  All the affair displays >>

  1. Hajime Tanaka, Yasuhisa Fujii. Editorial Comment. J Urol. 2021.05; 205 (5): 1319-1320. ( PubMed, DOI )

  2. Yuki Arita, Soichiro Yoshida, Yuma Waseda, Taro Takahara, Chikako Ishii, Ryo Ueda, Thomas C Kwee, Kei Miyahira, Ryota Ishii, Shigeo Okuda, Masahiro Jinzaki, Yasuhisa Fujii. Diagnostic value of computed high b-value whole-body diffusion-weighted imaging for primary prostate cancer. Eur J Radiol. 2021.04; 137 109581. ( PubMed, DOI )

  3. Toshiki Kijima, Hiroshi Fukushima, Shota Kusuhara, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Yasuyuki Sakai, Kazutaka Saito, Nobuaki Matsubara, Takeshi Yuasa, Hitoshi Masuda, Junji Yonese, Yukio Kageyama, Yasuhisa Fujii. Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review. Clin Genitourin Cancer. 2021.04; 19 (3): 208-216.e1. ( PubMed, DOI )

  4. Brittney H Cotta, Margaret F Meagher, Dattatraya Patil, Kazutaka Saito, Sunil H Patel, Devin N Patel, Nathan Miller, Raksha Dutt, Cathrine Keiner, Aaron W Bradshaw, Fang Wan, Ahmed Eldefrawy, Yosuke Yasuda, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh. Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC). BJU Int. 2021.04; 127 (3): 311-317. ( PubMed, DOI )

  5. Soichiro Yoshida, Yasuhisa Fujii. Editorial Comment to Utility of whole-body diffusion-weighted magnetic resonance imaging in the management of treatment-related neuroendocrine prostate cancer. IJU Case Rep. 2021.03; 4 (2): 73-74. ( PubMed, DOI )

  6. Toshiki Kijima, Hina Yamamoto, Kazutaka Saito, Shota Kusuhara, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Noboru Numao, Yasuyuki Sakai, Nobuaki Matsubara, Takeshi Yuasa, Hitoshi Masuda, Junji Yonese, Yukio Kageyama, Yasuhisa Fujii. Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab. Cancer Immunol Immunother. 2021.03; 70 (3): 657-665. ( PubMed, DOI )

  7. Shohei Fukuda, Kazutaka Saito, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Yukio Kageyama, Yasuhisa Fujii. Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab. J Immunother Cancer. 2021.02; 9 (2): ( PubMed, DOI )

  8. Takahiko Soma, Minato Yokoyama, Yusuke Uchida, Susumu Kirimura, Hajime Tanaka, Soichiro Yoshida, Yoh Matsuoka, Yasuhisa Fujii. Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report. Int Cancer Conf J. 2021.01; 10 (1): 20-23. ( PubMed, DOI )

  9. Yosuke Yasuda, Kazutaka Saito, Hajime Tanaka, Sho Uehara, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Kazunori Kihara, Yasuhisa Fujii. Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique. Int J Urol. 2021.01; 28 (3): 302-307. ( PubMed, DOI )

  10. Soichiro Yoshida, Hisashi Matsushima, Yasuhisa Fujii. Classification of oligometastatic prostate cancer with additional consideration for hormone sensitivity. World J Urol. 2021.01; ( PubMed, DOI )

  11. Hiroshi Fukushima, Soichiro Yoshida, Toshiki Kijima, Yuki Nakamura, Shohei Fukuda, Sho Uehara, Yosuke Yasuda, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka, Yasuhisa Fujii. Combination of Cisplatin and Irradiation Induces Immunogenic Cell Death and Potentiates Postirradiation Anti-PD-1 Treatment Efficacy in Urothelial Carcinoma. Int J Mol Sci. 2021.01; 22 (2): ( PubMed, DOI )

  12. Yasuda Y, Saito K, Tanaka H, Uehara S, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Kihara K, Fujii Y. . Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique Int J Urol.. 2020.12;

  13. Yasuda Y, Saito K, Tanaka H, Uehara S, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Kihara K, Fujii Y. Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patientsOutcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients Feasibility of a clampless and sutureless technique Int J Urol. 2020 Dec 9. doi: 10.1111/iju.14452. 2020.12;

  14. Yokoyama M, Masuda H, Ito M, Waseda Y, Moriyama S, Toide M, Uchida Y, Uehara S, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Longitudinal changes in patient-reported outcomes after artificial urinary sphincter implantation Low Urin Tract Symptoms. 2020.12;

  15. Yoshida S, Takahara T, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. . Can progressive site-directed therapy prolong the efficacy of subsequent androgen receptor axis-targeted drugs in oligometastatic castration-resistant prostate cancer? Int J Urol. 2020 Nov 2. doi: 10.1111/iju.14421.. 2020.11;

  16. Matsumoto H, Shiraishi K, Azuma H, Inoue K, Uemura H, Eto M, Ohyama C, Ogawa O, Kikuchi E, Kitamura H, Shinohara N, Takahashi S, Tsuzuki T, Nakagawa M, Narumi Y, Nishiyama H, Habuchi T, Hinotsu S, Fujii Y, Fujimoto K, Fujimoto H, Mizowaki T, Matsuyama H. Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision Int J Urol. 2020.09;

  17. Yamamoto S, Kageyama Y, Fujii Y, Aizawa T, Urakami S, Fukui I. Randomized Study of Postoperative Single Intravesical Instillation With Pirarubicin and Mitomycin C for Low-risk Bladder Cancer Anticancer Res. 2020.09;

  18. Suto EG, Mabuchi Y, Toyota S, Taguchi M, Naraoka Y, Itakura N, Matsuoka Y, Fujii Y, Miyasaka N, Akazawa C. Advantage of fat-derived CD73 positive cells from multiple human tissues, prospective isolated mesenchymal stromal cells Sci Rep. 2020.09;

  19. Kijima T, Yamamoto H, Saito K, Kusuhara S, Yoshida S, Yokoyama M, Matsuoka Y, Numao N, Sakai Y, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab Cancer Immunol Immunother. 2020.09;

  20. Yoh Matsuoka, Sho Uehara, Soichiro Yoshida, Hiroshi Tanaka, Hajime Tanaka, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Kazutaka Saito, Yasuhisa Fujii. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores: Spatial analysis using magnetic resonance-ultrasound fusion images. Int J Urol. 2020.09; 27 (9): 760-766. ( PubMed, DOI )

< PREV - NEXT >

To the head of this page.▲